Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07193095

This Project is a Three-arm RCT Evaluating Two, Single-session Behavioral Interventions for Adults With Chronic Musculoskeletal Pain (CMP) -- 1) Brief Mindfulness-Oriented Recovery Enhancement (B-MORE) vs. Empowered Relief (ER) -- Relative to the Traditional 8-week Version of MORE.

Brief MORE: A Mindfulness Intervention For Chronic Musculoskeletal Pain

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
39 (estimated)
Sponsor
Florida State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Researchers at Florida State University are investigating how the length of treatment influences outcomes for individuals with chronic musculoskeletal pain. The goal is to identify the most effective balance between treatment duration and pain relief. There are three treatment conditions in this study: two different brief pain management trainings and one standard-length training. Participants will be randomized to either of the brief trainings, attending a single, 2-hour, online training session, in which a trained facilitator will teach pain management techniques that are backed by research. If randomized to receive the standard-length training, participants will attend eight, 2-hour, online training session over eight weeks, in which a trained facilitator will also teach research-backed pain management techniques. Short surveys will be required at seven different time points: before starting treatment, immediately after the pain-management training, and then 2, 6, 12, 24, and 36 weeks after the training.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBrief Mindfulness Oriented Recovery EnhancementB-MORE is a 2-hour, single session adaptation of the traditional MORE program.
BEHAVIORALEmpowered ReliefER is an evidence-based 2-hour single session intervention for chronic pain.
BEHAVIORALMindfulness Oriented Recovery EnhancementMORE is an 8-week evidence-based treatment for chronic pain.

Timeline

Start date
2025-08-14
Primary completion
2026-09-01
Completion
2026-09-01
First posted
2025-09-25
Last updated
2025-09-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07193095. Inclusion in this directory is not an endorsement.